Matthew J Atherton

16PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyPredictive and prognostic markersHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 21, 2026
Development of tandem canine CAR T cells to enable comparative studies of aggressive B-cell lymphoma.

|Dec 11, 2025
Systemic STING agonist therapy drives expression of interferon stimulated genes and downstream production of cytokines in dogs with solid tumors.

Jennifer A Lenz, June DiBona, Matthew J Atherton

|Aug 04, 2025
Immune profiling of canine B cell lymphoma reveals cross-species conservation of prognostic markers.

Dillon Didehvar, Jennifer A Lenz, Brandon Peng

|Jan 31, 2025
Maximizing the dual benefit of pet dogs in cancer trials.

Jennifer A Lenz, Matthew J Atherton

|Jan 03, 2025
Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma.

Jennifer A Lenz, Brandon Peng, Charles-Antoine Assenmacher

|Apr 08, 2024
Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog.

Dillon S Didehvar, Matthew R Lanza, Matthew J Atherton

Pageof 3

Frequent Collaborators

10 joint publications

Jennifer A Lenz

3 joint publications

Nicola J Mason

2 joint publications

Antonia Rotolo

2 joint publications

Pengfei Yu